Clinical reassessment versus procalcitonin to reduce antibiotic use in community-acquired pneumonia The CLINPCT Randomized Controlled Trial

被引：0
|
作者：
Montassier, E. [1 ]
Moustafa, F. [2 ]
Trinh-Duc, A. [3 ]
Maignan, M. [4 ]
Annoot, C. [5 ]
Ogielska, M. [6 ]
Orer, P. L. [7 ]
Hardouin, J. B. [1 ]
Schotte, T. [8 ]
Bouget, J. [9 ]
Babaei, S. Agha [10 ]
Raynal, P. A. [11 ]
Eche, A. [12 ]
Benhizia-Benaouicha, N. [1 ]
Potel, G. [1 ]
Batard, E. [1 ]
机构：
[1] CHU Nantes, F-44035 Nantes 01, France
[2] CHU Clermont Ferrand, Clermont Ferrand, France
[3] CH Agen, Agen, France
[4] CHU Grenoble, F-38043 Grenoble, France
[5] CH La Roche Sur Yon, La Roche Sur Yon, France
[6] CHU Tours, Tours, France
[7] CHU Bobigny, Bobigny, France
[8] CHU Angers, Angers, France
[9] CHU Rennes, Rennes, France
[10] CHU Strasbourg, F-67000 Strasbourg, France
[11] CHU St Antoine, Paris, France
[12] CHU Hotel Dieu, Paris, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
CO-056
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [1] Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia a Randomized trial
    Christ-Crain, Miriam
    Stolz, Daiana
    Bingisser, Roland
    Muller, Christian
    Miedinger, David
    Huber, Peter R.
    Zimmerli, Werner
    Harbarth, Stephan
    Tamm, Michael
    Mueller, Beat
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (01) : 84 - 93
  • [2] Duration of Antibiotic Treatment in Community-Acquired Pneumonia A Multicenter Randomized Clinical Trial
    Uranga, Ane
    Espana, Pedro P.
    Bilbao, Amaia
    Quintana, Jose Maria
    Arriaga, Ignacio
    Intxausti, Maider
    Lobo, Jose Luis
    Tomas, Laura
    Camino, Jesus
    Nunez, Juan
    Capelastegui, Alberto
    JAMA INTERNAL MEDICINE, 2016, 176 (09) : 1257 - 1265
  • [3] Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial
    Silvia Fernández-Serrano
    Jordi Dorca
    Carolina Garcia-Vidal
    Núria Fernández-Sabé
    Jordi Carratalà
    Ana Fernández-Agüera
    Mercè Corominas
    Susana Padrones
    Francesc Gudiol
    Frederic Manresa
    Critical Care, 15
  • [4] Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial
    Fernandez-Serrano, Silvia
    Dorca, Jordi
    Garcia-Vidal, Carolina
    Fernandez-Sabe, Nuria
    Carratala, Jordi
    Fernandez-Agueera, Ana
    Corominas, Merce
    Padrones, Susana
    Gudiol, Francesc
    Manresa, Frederic
    CRITICAL CARE, 2011, 15 (02):
  • [5] Impact of comprehensive molecular testing to reduce antibiotic use in community-acquired pneumonia (RADICAP): a randomised, controlled, phase IV clinical trial protocol
    Abelenda-Alonso, Gabriela
    Rombauts, Alexander
    Gudiol, Carlota
    Meije, Yolanda
    Clemente, Mercedes
    Ortega, Lucia
    Ardanuy, Carmen
    Niubo, Jordi
    Padulles, Ariadna
    Videla, Sebastian
    Tebe, Cristian
    Carratala, Jordi
    BMJ OPEN, 2020, 10 (08): : e038957
  • [6] How to reduce antibiotic consumption for community-acquired pneumonia?
    Montassier, E.
    Goffinet, N.
    Potel, G.
    Batard, E.
    MEDECINE ET MALADIES INFECTIEUSES, 2013, 43 (02): : 52 - 59
  • [7] Impact of an Educational Program to Reduce Healthcare Resources in Community-Acquired Pneumonia: The EDUCAP Randomized Controlled Trial
    Adamuz, Jordi
    Viasus, Diego
    Simonetti, Antonella
    Jimenez-Martinez, Emilio
    Molero, Lorena
    Gonzalez-Samartino, Maribel
    Castillo, Elena
    Juve-Udina, Maria-Eulalia
    Alcocer, Maria-Jesus
    Hernandez, Carme
    Buera, Maria-Pilar
    Roel, Asuncion
    Abad, Emilia
    Zabalegui, Adelaida
    Ricart, Pilar
    Gonzalez, Anna
    Isla, Pilar
    Dorca, Jordi
    Garcia-Vidal, Carolina
    Carratala, Jordi
    PLOS ONE, 2015, 10 (10):
  • [8] Empiric antimicrobial therapy of community-acquired pneumonia: Clinical diagnosis versus procalcitonin levels
    Cunha, Burke A.
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2009, 41 (10) : 782 - 784
  • [9] Levofloxacin versus ceftriaxone and azithromycin for treating community-acquired pneumonia: a randomized clinical trial study
    Yadegarynia, Davood
    Tehrani, Shabnam
    Nejad, Fatemeh Maghsoudi
    Shojaeian, Fatemeh
    Keyvanfar, Amirreza
    IRANIAN JOURNAL OF MICROBIOLOGY, 2022, 14 (04) : 458 - 465
  • [10] Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia
    Huang, David T.
    Weissfeld, Lisa A.
    Kellum, John A.
    Yeally, Donald M.
    Kong, Lan
    Martino, Michael
    Angus, Derek C.
    ANNALS OF EMERGENCY MEDICINE, 2008, 52 (01) : 48 - 58
12345